Ingargiola Luisa

SEC source: 0001213900-26-077594 · ownership.xml · derivative · entry 1

Ingargiola Luisa · CIK 0001447277 · Chief Strategy Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 416,000

Underlying: Common Stock · 400,000 shares

Expires 2029-06-29

F1 · derivative.exercise_date: One hundred percent (100%) of the shares subject to the Option shall vest in full on the grant date.

SEC source: 0001493152-26-010588 · ownership.xml · nonDerivative · entry 1

Ingargiola Luisa · CIK 0001447277 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,757

F1 · shares: On March 15, 2026, the Reporting Person was granted 4,956 restricted stock units ("RSUs") under the Dragonfly Energy Holdings Corp. 2022 Equity Incentive Plan (the "Plan"), which will be settled in shares of common stock, par value $0.0001 (the "Common Stock"). The RSUs vest in three equal annual installments beginning on April 1, 2026, as long as the Reporting Person remains in continuous service with the Issuer through each vesting date.

F2 · balance_after: Reflects a one-for-10 reverse stock split effected by the Issuer on December 18, 2025. Includes 1,646 unvested RSUs remaining granted on April 12, 2024 under the Plan, which will be settled in shares of Common Stock. The remaining RSUs will vest in two equal installments on April 12, 2026 and April 12, 2027, as long as the Reporting Person remains in continuous service with the Issuer through each vesting date.

SEC source: 0001493152-26-007501 · ownership.xml · derivative · entry 1

Ingargiola Luisa · CIK 0001447277 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · See Footnote

Disclosed balance after: 50,000

Underlying: Class A Common Stock · 50,000 shares

Expires not disclosed

F1 · derivative.exercise_price: As described in the issuer's registration statement on Form S-1 (File No. 333-289204) under the heading "Description of Securities - Founder Shares," shares of Class B common stock, par value $0.0001 per share (the "Founder Shares"), of the issuer will automatically convert into shares of Class A common stock, par value $0.0001 per share, of the issuer at the time of the issuer's initial business combination, or earlier at the option of the holder, on a one-for-one basis, subject to certain adjustments, and have no expiration date.

F2 · price: Ms. Ingargiola received for her services as a director of the issuer an indirect interest in the Founder Shares through membership interests in New America Sponsor I LLC (the "Sponsor"). Ms. Ingargiola may be deemed to beneficially own 50,000 shares held by the Sponsor by virtue of her membership interest therein. Ms. Ingargiola does not have voting or dispositive control over the Sponsor and disclaims beneficial ownership except to the extent of her pecuniary interest.

F1 · derivative.exercise_date: As described in the issuer's registration statement on Form S-1 (File No. 333-289204) under the heading "Description of Securities - Founder Shares," shares of Class B common stock, par value $0.0001 per share (the "Founder Shares"), of the issuer will automatically convert into shares of Class A common stock, par value $0.0001 per share, of the issuer at the time of the issuer's initial business combination, or earlier at the option of the holder, on a one-for-one basis, subject to certain adjustments, and have no expiration date.

F1 · derivative.expiration_date: As described in the issuer's registration statement on Form S-1 (File No. 333-289204) under the heading "Description of Securities - Founder Shares," shares of Class B common stock, par value $0.0001 per share (the "Founder Shares"), of the issuer will automatically convert into shares of Class A common stock, par value $0.0001 per share, of the issuer at the time of the issuer's initial business combination, or earlier at the option of the holder, on a one-for-one basis, subject to certain adjustments, and have no expiration date.

F2 · ownership.direct: Ms. Ingargiola received for her services as a director of the issuer an indirect interest in the Founder Shares through membership interests in New America Sponsor I LLC (the "Sponsor"). Ms. Ingargiola may be deemed to beneficially own 50,000 shares held by the Sponsor by virtue of her membership interest therein. Ms. Ingargiola does not have voting or dispositive control over the Sponsor and disclaims beneficial ownership except to the extent of her pecuniary interest.

F2 · ownership.nature: Ms. Ingargiola received for her services as a director of the issuer an indirect interest in the Founder Shares through membership interests in New America Sponsor I LLC (the "Sponsor"). Ms. Ingargiola may be deemed to beneficially own 50,000 shares held by the Sponsor by virtue of her membership interest therein. Ms. Ingargiola does not have voting or dispositive control over the Sponsor and disclaims beneficial ownership except to the extent of her pecuniary interest.

SEC source: 0001819493-25-000083 · wk-form4_1748638797.xml · nonDerivative · entry 2

Ingargiola Luisa · CIK 0001447277 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 28,694

F3 · price: This sales price reflects a weighted average of multiple prices ranging from $3.30 to $3.35. Full information regarding the number of shares sold at each price will be provided to the Securities and Exchange Commission staff, the issuer or any security holder, upon request.

F2 · balance_after: Includes 28,694 unvested Restricted Stock Units ("RSUs").

SEC source: 0001819493-25-000083 · wk-form4_1748638797.xml · nonDerivative · entry 1

Ingargiola Luisa · CIK 0001447277 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 32,162

F1 · price: This sales price reflects a weighted average of multiple prices ranging from $3.30 to $3.40. Full information regarding the number of shares sold at each price will be provided to the Securities and Exchange Commission staff, the issuer or any security holder, upon request.

F2 · balance_after: Includes 28,694 unvested Restricted Stock Units ("RSUs").

SEC source: 0001819493-24-000123 · wk-form4_1720830641.xml · nonDerivative · entry 1

Ingargiola Luisa · CIK 0001447277 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 33,467

F1 · shares: The shares reported in this transaction represent Restricted Stock Units ("RSUs"), each of which represents a contingent right to receive one share of the Issuer's common stock upon settlement. The RSUs vest on the earlier of (i) the first anniversary of the Grant date and (ii) the day of the Company's 2025 Annual Meeting, subject to the Reporting Person's continuous service with Xos, Inc. through the vesting date.

F2 · balance_after: Includes 28,694 unvested RSUs.

SEC source: 0001477932-24-004105 · form4.xml · nonDerivative · entry 2

Ingargiola Luisa · CIK 0001447277 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 64,191

F2 · kind: These shares were issued to Ms. Ingargiola pursuant to a Director Agreement, dated March 1, 2019, by and between BioCorRx Inc. and Ms. Ingargiola. As compensation for her services, Ms. Ingargiola shall be issued, upon the last day of each fiscal quarter, provided Ms. Ingargiola is a member of the Board as of such date, the number of shares of the Company's common stock equivalent to $5,000 as determined based on the average closing price on the three trading days immediately preceding the last day of such quarter. The average closing price on the three trading days immediately preceding the date of this transaction was $0.49.

SEC source: 0001493152-24-014951 · ownership.xml · nonDerivative · entry 1

Ingargiola Luisa · CIK 0001447277 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 252,222

F1 · shares: On April 12, 2023, the Reporting Person was granted 222,222 restricted stock units ("RSUs") under the Dragonfly Energy Holdings Corp. 2022 Equity Incentive Plan, which will be settled in shares of common stock, par value $0.0001. The RSUs vest in three equal annual installments beginning on April 12, 2025, as long as the Reporting Person remains in continuous service with the Issuer through each vesting date.

SEC source: 0001477932-24-004105 · form4.xml · nonDerivative · entry 1

Ingargiola Luisa · CIK 0001447277 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 53,987

F1 · kind: These shares were issued to Ms. Ingargiola pursuant to a Director Agreement, dated March 1, 2019, by and between BioCorRx Inc. and Ms. Ingargiola. As compensation for her services, Ms. Ingargiola shall be issued, upon the last day of each fiscal quarter, provided Ms. Ingargiola is a member of the Board as of such date, the number of shares of the Company's common stock equivalent to $5,000 as determined based on the average closing price on the three trading days immediately preceding the last day of such quarter. The average closing price on the three trading days immediately preceding the date of this transaction was $0.90.

SEC source: 0001104659-24-038965 · tm249738-4_4seq1.xml · derivative · entry 5

Ingargiola Luisa · CIK 0001447277 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 270,853 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: Each deferred share unit ("DSU") represented a contingent right to receive one ElectraMeccanica Share (or, at the election of the reporting person and subject to the approval of the Plan Administrator (as defined in the issuer's 2020 Stock Incentive Plan (the "Plan")), the cash value thereof) on the settlement date. Pursuant to the Arrangement Agreement, each DSU that was outstanding immediately prior to the Effective Time vested and was settled by ElectraMeccanica in exchange for one ElectraMeccanica Share.

F2 · derivative.exercise_date: Each deferred share unit ("DSU") represented a contingent right to receive one ElectraMeccanica Share (or, at the election of the reporting person and subject to the approval of the Plan Administrator (as defined in the issuer's 2020 Stock Incentive Plan (the "Plan")), the cash value thereof) on the settlement date. Pursuant to the Arrangement Agreement, each DSU that was outstanding immediately prior to the Effective Time vested and was settled by ElectraMeccanica in exchange for one ElectraMeccanica Share.

F5 · derivative.exercise_date: The DSUs vested in full upon grant.

F2 · derivative.expiration_date: Each deferred share unit ("DSU") represented a contingent right to receive one ElectraMeccanica Share (or, at the election of the reporting person and subject to the approval of the Plan Administrator (as defined in the issuer's 2020 Stock Incentive Plan (the "Plan")), the cash value thereof) on the settlement date. Pursuant to the Arrangement Agreement, each DSU that was outstanding immediately prior to the Effective Time vested and was settled by ElectraMeccanica in exchange for one ElectraMeccanica Share.

F5 · derivative.expiration_date: The DSUs vested in full upon grant.

SEC source: 0001104659-24-038965 · tm249738-4_4seq1.xml · derivative · entry 4

Ingargiola Luisa · CIK 0001447277 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 10,264 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: Each deferred share unit ("DSU") represented a contingent right to receive one ElectraMeccanica Share (or, at the election of the reporting person and subject to the approval of the Plan Administrator (as defined in the issuer's 2020 Stock Incentive Plan (the "Plan")), the cash value thereof) on the settlement date. Pursuant to the Arrangement Agreement, each DSU that was outstanding immediately prior to the Effective Time vested and was settled by ElectraMeccanica in exchange for one ElectraMeccanica Share.

F2 · derivative.exercise_date: Each deferred share unit ("DSU") represented a contingent right to receive one ElectraMeccanica Share (or, at the election of the reporting person and subject to the approval of the Plan Administrator (as defined in the issuer's 2020 Stock Incentive Plan (the "Plan")), the cash value thereof) on the settlement date. Pursuant to the Arrangement Agreement, each DSU that was outstanding immediately prior to the Effective Time vested and was settled by ElectraMeccanica in exchange for one ElectraMeccanica Share.

F4 · derivative.exercise_date: The DSUs vested over a period of one year from September 22, 2021.

F2 · derivative.expiration_date: Each deferred share unit ("DSU") represented a contingent right to receive one ElectraMeccanica Share (or, at the election of the reporting person and subject to the approval of the Plan Administrator (as defined in the issuer's 2020 Stock Incentive Plan (the "Plan")), the cash value thereof) on the settlement date. Pursuant to the Arrangement Agreement, each DSU that was outstanding immediately prior to the Effective Time vested and was settled by ElectraMeccanica in exchange for one ElectraMeccanica Share.

F4 · derivative.expiration_date: The DSUs vested over a period of one year from September 22, 2021.

SEC source: 0001104659-24-038965 · tm249738-4_4seq1.xml · derivative · entry 3

Ingargiola Luisa · CIK 0001447277 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 8,797 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: Each deferred share unit ("DSU") represented a contingent right to receive one ElectraMeccanica Share (or, at the election of the reporting person and subject to the approval of the Plan Administrator (as defined in the issuer's 2020 Stock Incentive Plan (the "Plan")), the cash value thereof) on the settlement date. Pursuant to the Arrangement Agreement, each DSU that was outstanding immediately prior to the Effective Time vested and was settled by ElectraMeccanica in exchange for one ElectraMeccanica Share.

F2 · derivative.exercise_date: Each deferred share unit ("DSU") represented a contingent right to receive one ElectraMeccanica Share (or, at the election of the reporting person and subject to the approval of the Plan Administrator (as defined in the issuer's 2020 Stock Incentive Plan (the "Plan")), the cash value thereof) on the settlement date. Pursuant to the Arrangement Agreement, each DSU that was outstanding immediately prior to the Effective Time vested and was settled by ElectraMeccanica in exchange for one ElectraMeccanica Share.

F3 · derivative.exercise_date: The DSUs vested over a period of one year from July 22, 2020.

F2 · derivative.expiration_date: Each deferred share unit ("DSU") represented a contingent right to receive one ElectraMeccanica Share (or, at the election of the reporting person and subject to the approval of the Plan Administrator (as defined in the issuer's 2020 Stock Incentive Plan (the "Plan")), the cash value thereof) on the settlement date. Pursuant to the Arrangement Agreement, each DSU that was outstanding immediately prior to the Effective Time vested and was settled by ElectraMeccanica in exchange for one ElectraMeccanica Share.

F3 · derivative.expiration_date: The DSUs vested over a period of one year from July 22, 2020.

SEC source: 0001104659-24-038965 · tm249738-4_4seq1.xml · nonDerivative · entry 2

Ingargiola Luisa · CIK 0001447277 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

F1 · price: On March 26, 2024, Xos, Inc. ("Xos") acquired all of the issued and outstanding common shares (the "ElectraMeccanica Shares") of ElectraMeccanica Vehicles Corp. ("ElectraMeccanica") pursuant to a plan of arrangement (the "Plan of Arrangement") under the Business Corporations Act (British Columbia) (the "Arrangement"). Under the terms of the arrangement agreement, dated January 11, 2024, by and between ElectraMeccanica and Xos (as amended, the "Arrangement Agreement"), and the Plan of Arrangement, at the effective time of the Arrangement (the "Effective Time"), each ElectraMeccanica Share outstanding immediately prior to the Effective Time was transferred to Xos in exchange for 0.0143739 shares of Xos common stock.

SEC source: 0001104659-24-038965 · tm249738-4_4seq1.xml · nonDerivative · entry 1

Ingargiola Luisa · CIK 0001447277 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 332,138

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · price: Each deferred share unit ("DSU") represented a contingent right to receive one ElectraMeccanica Share (or, at the election of the reporting person and subject to the approval of the Plan Administrator (as defined in the issuer's 2020 Stock Incentive Plan (the "Plan")), the cash value thereof) on the settlement date. Pursuant to the Arrangement Agreement, each DSU that was outstanding immediately prior to the Effective Time vested and was settled by ElectraMeccanica in exchange for one ElectraMeccanica Share.

SEC source: 0001104659-24-035743 · tm249125-1_4seq1.xml · derivative · entry 1

Ingargiola Luisa · CIK 0001447277 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 270,853

Underlying: Common Stock · 167,614 shares

Expires not disclosed

F1 · derivative.exercise_price: Each deferred share unit ("DSU") represents a right to receive one share of the issuer's common stock (or, at the election of the reporting person and subject to the approval of the Plan Administrator (as defined in the issuer's 2020 Stock Incentive Plan (the "Plan")), the cash value thereof) on the settlement date.

F2 · derivative.exercise_date: The DSUs vested in full upon grant and will be settled on the reporting person's Termination Date or Separation from Service, as applicable (each, as defined in the Plan).

F2 · derivative.expiration_date: The DSUs vested in full upon grant and will be settled on the reporting person's Termination Date or Separation from Service, as applicable (each, as defined in the Plan).

F3 · balance_after: Does not include 19,061 DSUs that were previously granted to the reporting person with different vesting terms.

SEC source: 0001477932-24-000035 · form4.xml · nonDerivative · entry 1

Ingargiola Luisa · CIK 0001447277 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 48,421

F1 · kind: These shares were issued to Ms. Ingargiola pursuant to a Director Agreement, dated March 1, 2019, by and between BioCorRx Inc. and Ms. Ingargiola. As compensation for her services, Ms. Ingargiola shall be issued, upon the last day of each fiscal quarter, provided Ms. Ingargiola is a member of the Board as of such date, the number of shares of the Company's common stock equivalent to $5,000 as determined based on the average closing price on the three trading days immediately preceding the last day of such quarter. The average closing price on the three trading days immediately preceding the date of this transaction was $0.81.

SEC source: 0001104659-23-125520 · tm2332677-8_4seq1.xml · derivative · entry 1

Ingargiola Luisa · CIK 0001447277 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 103,239

Underlying: Common Stock · 76,923 shares

Expires not disclosed

F1 · derivative.exercise_price: Each deferred share unit ("DSU") represents a right to receive one share of the issuer's common stock (or, at the election of the reporting person and subject to the approval of the Plan Administrator (as defined in the issuer's 2020 Stock Incentive Plan (the "Plan")), the cash value thereof) on the settlement date.

F2 · derivative.exercise_date: The DSUs vested in full upon grant and will be settled on the reporting person's Termination Date or Separation from Service, as applicable (each, as defined in the Plan).

F2 · derivative.expiration_date: The DSUs vested in full upon grant and will be settled on the reporting person's Termination Date or Separation from Service, as applicable (each, as defined in the Plan).

F3 · balance_after: Does not include 19,061 DSUs that were previously granted to the reporting person with different vesting terms.

SEC source: 0001477932-23-007297 · primary_doc.xml · nonDerivative · entry 1

Ingargiola Luisa · CIK 0001447277 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 42,248

F1 · kind: These shares were issued to Ms. Ingargiola pursuant to a Director Agreement, dated March 1, 2019, by and between BioCorRx Inc. and Ms. Ingargiola. As compensation for her services, Ms. Ingargiola shall be issued, upon the last day of each fiscal quarter, provided Ms. Ingargiola is a member of the Board as of such date, the number of shares of the Company's common stock equivalent to $5,000 as determined based on the average closing price on the three trading days immediately preceding the last day of such quarter. The average closing price on the three trading days immediately preceding the date of this transaction was $1.75.

SEC source: 0001104659-23-082468 · tm2321515-1_4seq1.xml · derivative · entry 1

Ingargiola Luisa · CIK 0001447277 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 26,316

Underlying: Common Stock · 26,316 shares

Expires not disclosed

F1 · derivative.exercise_price: Each deferred share unit ("DSU") represents a right to receive one share of the issuer's common stock (or, at the election of the reporting person and subject to the approval of the Plan Administrator (as defined in the issuer's 2020 Stock Incentive Plan (the "Plan")), the cash value thereof) on the settlement date.

F2 · kind: The DSUs reported in this Form 4 represent the annual equity grant in connection with service on the issuer's board of directors for fiscal year 2022, which were not previously granted due to an administrative oversight.

F3 · derivative.exercise_date: The DSUs vested in full upon grant and will be settled on the reporting person's Termination Date or Separation from Service, as applicable (each, as defined in the Plan).

F3 · derivative.expiration_date: The DSUs vested in full upon grant and will be settled on the reporting person's Termination Date or Separation from Service, as applicable (each, as defined in the Plan).

SEC source: 0001477932-23-005018 · form4.xml · nonDerivative · entry 1

Ingargiola Luisa · CIK 0001447277 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 39,390

F1 · kind: These shares were issued to Ms. Ingargiola pursuant to a Director Agreement, dated March 1, 2019, by and between BioCorRx Inc. and Ms. Ingargiola. As compensation for her services, Ms. Ingargiola shall be issued, upon the last day of each fiscal quarter, provided Ms. Ingargiola is a member of the Board as of such date, the number of shares of the Company's common stock equivalent to $5,000 as determined based on the average closing price on the three trading days immediately preceding the last day of such quarter. The average closing price on the three trading days immediately preceding the date of this transaction was $1.73.

SEC source: 0001477932-23-002229 · form4.xml · nonDerivative · entry 1

Ingargiola Luisa · CIK 0001447277 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 36,499

F1 · kind: These shares were issued to Ms. Ingargiola pursuant to a Director Agreement, dated March 1, 2019, by and between BioCorRx Inc. and Ms. Ingargiola. As compensation for her services, Ms. Ingargiola shall be issued, upon the last day of each fiscal quarter, provided Ms. Ingargiola is a member of the Board as of such date, the number of shares of the Company's common stock equivalent to $5,000 as determined based on the average closing price on the three trading days immediately preceding the last day of such quarter. The average closing price on the three trading days immediately preceding the date of this transaction was $1.77.

SEC source: 0001477932-23-000179 · form4.xml · nonDerivative · entry 1

Ingargiola Luisa · CIK 0001447277 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 33,675

F1 · kind: These shares were issued to Ms. Ingargiola pursuant to a Director Agreement, dated March 1, 2019, by and between BioCorRx Inc. and Ms. Ingargiola. As compensation for her services, Ms. Ingargiola shall be issued, upon the last day of each fiscal quarter, provided Ms. Ingargiola is a member of the Board as of such date, the number of shares of the Company's common stock equivalent to $5,000 as determined based on the average closing price on the three trading days immediately preceding the last day of such quarter. The average closing price on the three trading days immediately preceding the date of this transaction was $0.94.

SEC source: 0001575705-22-000685 · ownership.xml · derivative · entry 1

Ingargiola Luisa · CIK 0001447277 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 330,812

Underlying: Common Stock · 25,000 shares

Expires 2027-09-29

F1 · security: The options become exercisable and vest in equal monthly installments over a two-year period commencing on the Transaction Date.

F2 · price: The options were issued as incentive compensation for services under the Company's 2017 Omnibus Equity Incentive Plan

F1 · derivative.exercise_date: The options become exercisable and vest in equal monthly installments over a two-year period commencing on the Transaction Date.

F3 · balance_after: Aggregate number of stock options beneficially owned as of the Transaction Date irrespective of exercise price and expiration date.

SEC source: 0001477932-22-007466 · form4.xml · nonDerivative · entry 1

Ingargiola Luisa · CIK 0001447277 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 28,356

F1 · kind: These shares were issued to Ms. Ingargiola pursuant to a Director Agreement, dated March 1, 2019, by and between BioCorRx Inc. and Ms. Ingargiola. As compensation for her services, Ms. Ingargiola shall be issued, upon the last day of each fiscal quarter, provided Ms. Ingargiola is a member of the Board as of such date, the number of shares of the Company's common stock equivalent to $5,000 as determined based on the average closing price on the three trading days immediately preceding the last day of such quarter. The average closing price on the three trading days immediately preceding the date of this transaction was $2.04.

SEC source: 0001575705-22-000470 · ownership.xml · derivative · entry 1

Ingargiola Luisa · CIK 0001447277 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 305,812

Underlying: Common Stock · 25,000 shares

Expires 2027-06-29

F1 · security: The options become exercisable and vest in equal monthly installments over a two-year period commencing on the Transaction Date.

F2 · price: The options were issued as incentive compensation for services under the Company's 2017 Omnibus Equity Incentive Plan.

F1 · derivative.exercise_date: The options become exercisable and vest in equal monthly installments over a two-year period commencing on the Transaction Date.

F3 · balance_after: Aggregate number of stock options beneficially owned as of the Transaction Date irrespective of exercise price and expiration date.

SEC source: 0001477932-22-004882 · form4.xml · nonDerivative · entry 1

Ingargiola Luisa · CIK 0001447277 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 25,906

F1 · kind: These shares were issued to Ms. Ingargiola pursuant to a Director Agreement, dated March 1, 2019, by and between BioCorRx Inc. and Ms. Ingargiola. As compensation for her services, Ms. Ingargiola shall be issued, upon the last day of each fiscal quarter, provided Ms. Ingargiola is a member of the Board as of such date, the number of shares of the Company's common stock equivalent to $5,000 as determined based on the average closing price on the three trading days immediately preceding the last day of such quarter. The average closing price on the three trading days immediately preceding the date of this transaction was $2.39.

SEC source: 0001477932-22-002034 · form4.xml · nonDerivative · entry 2

Ingargiola Luisa · CIK 0001447277 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 25,222

F2 · kind: These shares were issued to Ms. Ingargiola pursuant to the Director Agreement referenced in footnote 1. The average closing price on the three trading days immediately preceding the date of this transaction was $3.55.

SEC source: 0001575705-22-000415 · ownership.xml · derivative · entry 6

Ingargiola Luisa · CIK 0001447277 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 280,812

Underlying: Common Stock · 25,000 shares

Expires 2027-03-30

F1 · security: The stock option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 06/17/21.

F4 · price: The options were issued as incentive compensation for services under the Company's 2017 Omnibus Equity Incentive Plan.

F3 · derivative.exercise_date: The options become exercisable and vest in equal monthly installments over a two-year period commencing on the Transaction Date.

F5 · balance_after: Aggregate number of stock options beneficially owned as of the Transaction Date irrespective of exercise price and expiration date.

SEC source: 0001477932-22-002034 · form4.xml · nonDerivative · entry 1

Ingargiola Luisa · CIK 0001447277 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 23,814

F1 · kind: These shares were issued to Ms. Ingargiola pursuant to a Director Agreement, dated March 1, 2019, by and between BioCorRx Inc. and Ms. Ingargiola. As compensation for her services, Ms. Ingargiola shall be issued, upon the last day of each fiscal quarter, provided Ms. Ingargiola is a member of the Board as of such date, the number of shares of the Company's common stock equivalent to $5,000 as determined based on the average closing price on the three trading days immediately preceding the last day of such quarter. The average closing price on the three trading days immediately preceding the date of this transaction was $4.38.

SEC source: 0001575705-22-000415 · ownership.xml · derivative · entry 7

Ingargiola Luisa · CIK 0001447277 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 255,812

Underlying: Common Stock · 25,000 shares

Expires 2026-12-30

F1 · security: The stock option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 06/17/21.

F4 · price: The options were issued as incentive compensation for services under the Company's 2017 Omnibus Equity Incentive Plan.

F3 · derivative.exercise_date: The options become exercisable and vest in equal monthly installments over a two-year period commencing on the Transaction Date.

F5 · balance_after: Aggregate number of stock options beneficially owned as of the Transaction Date irrespective of exercise price and expiration date.

SEC source: 0001477932-21-009297 · form4.xml · nonDerivative · entry 2

Ingargiola Luisa · CIK 0001447277 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 22,673

F2 · kind: These shares were issued to Ms. Ingargiola pursuant to a Director Agreement, dated March 1, 2019, by and between BioCorRx Inc. and Ms. Ingargiola. As compensation for her services, Ms. Ingargiola shall be issued, upon the last day of each fiscal quarter, provided Ms. Ingargiola is a member of the Board as of such date, the number of shares of the Company's common stock equivalent to $5,000 as determined based on the average closing price on the three trading days immediately preceding the last day of such quarter. The average closing price on the three trading days immediately preceding the date of this transaction was $3.62.

SEC source: 0001575705-22-000415 · ownership.xml · derivative · entry 8

Ingargiola Luisa · CIK 0001447277 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 230,812

Underlying: Common Stock · 25,000 shares

Expires 2026-09-29

F1 · security: The stock option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 06/17/21.

F4 · price: The options were issued as incentive compensation for services under the Company's 2017 Omnibus Equity Incentive Plan.

F3 · derivative.exercise_date: The options become exercisable and vest in equal monthly installments over a two-year period commencing on the Transaction Date.

F5 · balance_after: Aggregate number of stock options beneficially owned as of the Transaction Date irrespective of exercise price and expiration date.

SEC source: 0001477932-21-009297 · form4.xml · nonDerivative · entry 1

Ingargiola Luisa · CIK 0001447277 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 21,292

F1 · kind: These shares were issued to Ms. Ingargiola pursuant to a Director Agreement, dated March 1, 2019, by and between BioCorRx Inc. and Ms. Ingargiola. As compensation for her services, Ms. Ingargiola shall be issued, upon the last day of each fiscal quarter, provided Ms. Ingargiola is a member of the Board as of such date, the number of shares of the Company's common stock equivalent to $5,000 as determined based on the average closing price on the three trading days immediately preceding the last day of such quarter. The average closing price on the three trading days immediately preceding the date of this transaction was $4.13.

SEC source: 0001575705-22-000415 · ownership.xml · derivative · entry 9

Ingargiola Luisa · CIK 0001447277 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 205,812

Underlying: Common Stock · 25,000 shares

Expires 2026-06-29

F1 · security: The stock option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 06/17/21.

F4 · price: The options were issued as incentive compensation for services under the Company's 2017 Omnibus Equity Incentive Plan.

F3 · derivative.exercise_date: The options become exercisable and vest in equal monthly installments over a two-year period commencing on the Transaction Date.

F5 · balance_after: Aggregate number of stock options beneficially owned as of the Transaction Date irrespective of exercise price and expiration date.

SEC source: 0001575705-22-000415 · ownership.xml · derivative · entry 13

Ingargiola Luisa · CIK 0001447277 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 194,711

Underlying: Common Stock · 12,375 shares

Expires 2024-09-28

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · security: The stock option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 06/17/21.

F4 · price: The options were issued as incentive compensation for services under the Company's 2017 Omnibus Equity Incentive Plan.

F1 · derivative.exercise_date: The stock option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 06/17/21.

F5 · balance_after: Aggregate number of stock options beneficially owned as of the Transaction Date irrespective of exercise price and expiration date.

SEC source: 0001575705-22-000415 · ownership.xml · derivative · entry 12

Ingargiola Luisa · CIK 0001447277 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 188,254

Underlying: Common Stock · 6,187 shares

Expires 2024-06-28

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · security: The stock option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 06/17/21.

F4 · price: The options were issued as incentive compensation for services under the Company's 2017 Omnibus Equity Incentive Plan.

F1 · derivative.exercise_date: The stock option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 06/17/21.

F5 · balance_after: Aggregate number of stock options beneficially owned as of the Transaction Date irrespective of exercise price and expiration date.

SEC source: 0001575705-22-000415 · ownership.xml · derivative · entry 11

Ingargiola Luisa · CIK 0001447277 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 182,337

Underlying: Common Stock · 6,187 shares

Expires 2024-03-29

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · security: The stock option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 06/17/21.

F4 · price: The options were issued as incentive compensation for services under the Company's 2017 Omnibus Equity Incentive Plan.

F1 · derivative.exercise_date: The stock option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 06/17/21.

F5 · balance_after: Aggregate number of stock options beneficially owned as of the Transaction Date irrespective of exercise price and expiration date.

SEC source: 0001575705-22-000415 · ownership.xml · derivative · entry 10

Ingargiola Luisa · CIK 0001447277 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 180,812

Underlying: Common Stock · 1,525 shares

Expires 2023-12-30

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · security: The stock option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 06/17/21.

F4 · price: The options were issued as incentive compensation for services under the Company's 2017 Omnibus Equity Incentive Plan.

F1 · derivative.exercise_date: The stock option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 06/17/21.

F5 · balance_after: Aggregate number of stock options beneficially owned as of the Transaction Date irrespective of exercise price and expiration date.

SEC source: 0001575705-22-000415 · ownership.xml · nonDerivative · entry 5

Ingargiola Luisa · CIK 0001447277 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

F5 · security: Aggregate number of stock options beneficially owned as of the Transaction Date irrespective of exercise price and expiration date.

F2 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 06/17/21.

F6 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.31 to $5.38.

SEC source: 0001575705-22-000415 · ownership.xml · nonDerivative · entry 4

Ingargiola Luisa · CIK 0001447277 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 26,274

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The stock option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 06/17/21.

SEC source: 0001575705-22-000415 · ownership.xml · nonDerivative · entry 3

Ingargiola Luisa · CIK 0001447277 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 13,899

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The stock option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 06/17/21.

SEC source: 0001575705-22-000415 · ownership.xml · nonDerivative · entry 2

Ingargiola Luisa · CIK 0001447277 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,712

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The stock option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 06/17/21.

SEC source: 0001575705-22-000415 · ownership.xml · nonDerivative · entry 1

Ingargiola Luisa · CIK 0001447277 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,525

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The stock option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 06/17/21.

SEC source: 0001477932-21-002005 · form4.xml · nonDerivative · entry 1

Ingargiola Luisa · CIK 0001447277 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,082

F1 · kind: These shares were issued to Ms. Ingragiola pursuant to a Director Agreement, dated March 1, 2019, by and between BioCorRx Inc. and Ms. Ingragiola. As compensation for her services, Ms. Ingragiola shall be issued, upon the last day of each fiscal quarter, provided Ms. Ingragiola is a member of the Board as of such date, the number of shares of the Company's common stock equivalent to $5,000 as determined based on the average closing price on the three trading days immediately preceding the last day of such quarter. The average closing price on the three trading days immediately preceding the date of this transaction was $2.15.

SEC source: 0001575705-22-000415 · ownership.xml · derivative · entry 14

Ingargiola Luisa · CIK 0001447277 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 207,086

Underlying: Common Stock · 25,000 shares

Expires 2026-03-30

F1 · security: The stock option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 06/17/21.

F4 · price: The options were issued as incentive compensation for services under the Company's 2017 Omnibus Equity Incentive Plan.

F3 · derivative.exercise_date: The options become exercisable and vest in equal monthly installments over a two-year period commencing on the Transaction Date.

F5 · balance_after: Aggregate number of stock options beneficially owned as of the Transaction Date irrespective of exercise price and expiration date.

SEC source: 0001477932-21-000044 · form4.xml · nonDerivative · entry 2

Ingargiola Luisa · CIK 0001447277 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 17,756

F1 · kind: These shares were issued to Ms. Ingargiola pursuant to a Director Agreement, dated March 1, 2019, by and between BioCorRx Inc. and Ms. Ingargiola. As compensation for her services, Ms. Ingargiola shall be issued, upon the last day of each fiscal quarter, provided Ms. Ingargiola is a member of the Board as of such date, the number of shares of the Company's common stock equivalent to $5,000 as determined based on the average closing price on the three trading days immediately preceding the last day of such quarter. The average closing price on the three trading days immediately preceding September 30, 2020 was $1.90. The average closing price on the three trading days immediately preceding December 31, 2020 was $1.02.

SEC source: 0001575705-22-000415 · ownership.xml · derivative · entry 15

Ingargiola Luisa · CIK 0001447277 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 182,086

Underlying: Common Stock · 25,000 shares

Expires 2025-12-30

F1 · security: The stock option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 06/17/21.

F4 · price: The options were issued as incentive compensation for services under the Company's 2017 Omnibus Equity Incentive Plan.

F3 · derivative.exercise_date: The options become exercisable and vest in equal monthly installments over a two-year period commencing on the Transaction Date.

F5 · balance_after: Aggregate number of stock options beneficially owned as of the Transaction Date irrespective of exercise price and expiration date.

SEC source: 0001575705-20-000273 · ownership.xml · derivative · entry 7

Ingargiola Luisa · CIK 0001447277 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 179,285

Underlying: Common Stock · 2,063 shares

Expires 2025-03-28

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The stock option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 08/03/2020.

F4 · price: The options were issued as incentive compensation for services under the Company's Omnibus Equity Incentive Plan.

F3 · derivative.exercise_date: The options became exercisable and vest in equal installments over a two-year period commencing on the issuance date.

F5 · balance_after: Aggregate number of stock options beneficially owned as of the Transaction Date irrespective of exercise price and expiration date.

SEC source: 0001575705-20-000273 · ownership.xml · derivative · entry 6

Ingargiola Luisa · CIK 0001447277 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 175,160

Underlying: Common Stock · 4,125 shares

Expires 2024-12-28

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The stock option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 08/03/2020.

F4 · price: The options were issued as incentive compensation for services under the Company's Omnibus Equity Incentive Plan.

F3 · derivative.exercise_date: The options became exercisable and vest in equal installments over a two-year period commencing on the issuance date.

F5 · balance_after: Aggregate number of stock options beneficially owned as of the Transaction Date irrespective of exercise price and expiration date.

SEC source: 0001575705-20-000273 · ownership.xml · derivative · entry 5

Ingargiola Luisa · CIK 0001447277 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 157,086

Underlying: Common Stock · 18,074 shares

Expires 2024-09-28

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The stock option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 08/03/2020.

F4 · price: The options were issued as incentive compensation for services under the Company's Omnibus Equity Incentive Plan.

F3 · derivative.exercise_date: The options became exercisable and vest in equal installments over a two-year period commencing on the issuance date.

F5 · balance_after: Aggregate number of stock options beneficially owned as of the Transaction Date irrespective of exercise price and expiration date.